PRESS RELEASE published on 07/25/2025 at 08:45, 6 months 5 days ago Inside Information / Other news releases Adocia and Tonghua Dongbao announce positive Phase 3 results of Ultra-Rapid Insulin BioChaperone® Lispro (THDB0206 injection) in Type 2 Diabetes. Significant HbA1c reduction and improved post-meal blood glucose levels compared to Humalog® Type 2 Diabetes Phase 3 Results ADOCIA Tonghua Dongbao Ultra-Rapid Insulin
BRIEF published on 04/04/2025 at 11:21, 9 months 26 days ago Vester Finance reduces its stake in ADOCIA Voting Rights Actions Threshold Crossing ADOCIA Vester Finance
BRIEF published on 02/28/2025 at 19:33, 11 months 1 day ago Adocia Completes €9.7 Million Private Placement Private Placement Share Capital Biopharmaceutical Diabetes Treatment ADOCIA
PRESS RELEASE published on 02/28/2025 at 19:28, 11 months 1 day ago Inside Information / Other news releases Adocia successfully settles and delivers €9.7 million private placement, issuing 2,125,000 new ordinary shares with warrants. Admittance to trading on Euronext Paris confirmed Private Placement Euronext Paris Diabetes Biopharmaceutical ADOCIA
BRIEF published on 02/26/2025 at 08:47, 11 months 4 days ago ADOCIA strengthens its cash flow with a private placement of 9.7 million euros Private Placement Capital Increase Biopharmaceutical Third Party Capital Financial Tonnage
PRESS RELEASE published on 02/26/2025 at 08:42, 11 months 4 days ago Inside Information / Operations of the issuer (acquisitions, sales...) Adocia successfully completes €9.7 million private placement, extending cash runway to Q2 2026. New shares issued with warrants attached. Notable investors include Gerard Soula and Armistice Capital Private Placement Investors New Shares Cash Runway ADOCIA
BRIEF published on 02/25/2025 at 19:08, 11 months 4 days ago Adocia: Financial report for the fourth quarter of 2024 Diabetes Treasury Partnership ADOCIA BioChaperone®
PRESS RELEASE published on 02/25/2025 at 19:03, 11 months 4 days ago Inside Information / News release on accounts, results Adocia reports Q4 2024 financial results, €7.5M cash position, partnership updates with Sanofi, and business priorities. Strong revenue growth detailed in press release Financial Results Revenue Growth ADOCIA Partnership Updates Business Priorities
BRIEF published on 02/11/2025 at 14:03, 11 months 19 days ago Threshold crossing at ADOCIA by the CDC Actions Threshold Crossing Bpifrance ADOCIA Deposit Fund
BRIEF published on 12/23/2024 at 18:40, 1 year 1 month ago Adocia announces its participation in key conferences in 2025 Investors Biopharmaceutical ADOCIA Conférences 2025 Diabetes And Obesity
Published on 01/30/2026 at 14:00, 2 hours 3 minutes ago CCL to Hold Live Webcast to Discuss Fourth Quarter and Year End 2025 Results, Thursday, February 26, 2026, at 7:30 a.m. ET
Published on 01/30/2026 at 08:35, 7 hours 28 minutes ago Alaska Energy Metals Announces Closing Of Life Offering of Units
Published on 01/30/2026 at 08:00, 8 hours 3 minutes ago Troubadour Resources Intercepts Target Mineralization Near Surface during Phase 1 of the Multi-Phase Drill Program at Senneville Gold-Silver-Copper Property
Published on 01/30/2026 at 02:15, 13 hours 48 minutes ago Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 16 hours 3 minutes ago LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/30/2026 at 15:57, 5 minutes ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 01/30/2026 at 15:55, 7 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 01/30/2026 at 15:55, 7 minutes ago Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc
Published on 01/29/2026 at 18:00, 22 hours 3 minutes ago GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 22 hours 18 minutes ago LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 22 hours 18 minutes ago Cegedim generated LFL revenue growth of 1.1% in 2025
